Showing results (1341-1350 of 1,798) with videos related to
Sort By:
Pageof 180
Journal of Gastrointestinal Cancer|July 10, 2021
Laparoscopic Partial Gastrectomy for Large Gastric GISTsAmr Abouzid, Ahmed Setit, Adel Fathi, et al.Journal of Gastrointestinal Cancer|October 3, 2020
Assessment of oncogenic role of intestinal microbiota in colorectal cancer patientsTha'ir Abid D'asheesh, Bashdar Mahmud Hussen, Ali H Al-Marzoqi, et al.Journal of Gastrointestinal Cancer|October 2, 2020
Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of GrowthBrian I Carr, V Guerra, R Donghia, et al.Journal of Gastrointestinal Cancer|January 18, 2023
Oligometastatic Colorectal Cancer: A Review of Definitions and Patient Selection for Local TherapiesEric D Miller, Kathryn E Hitchcock, Paul B RomesserJournal of Gastrointestinal Cancer|January 9, 2023
The Role of Probiotics in Colorectal Cancer: A ReviewShahad M Khaleel, Sadeel A Shanshal, Musab M KhalafJournal of Gastrointestinal Cancer|January 9, 2023
A Cost-effectiveness Analysis of Adding Cetuximab to the First-line Treatment of Metastatic Colorectal Carcinoma in Iran; Considering Genetic Screening for Precision MedicineNazila Yousefi, Alireza Salimi, Ghader Mohammadnezhad, et al.Journal of Gastrointestinal Cancer|January 9, 2023
Multi-Disciplinary Management in Rectal Cancer Survivorship: A Clinical Practice ReviewHilary Chan, Marissa B Savoie, Amir Munir, et al.Journal of Gastrointestinal Cancer|December 20, 2022
Caudal-to-Cranial Approach for Right Colectomy with Complete Mesocolic Excision in Colon Cancer: A Systematic Review and Meta-analysisMohamed Maatouk, Yacine Ben Safta, Ghassen Hamdi Kbir, et al.Journal of Gastrointestinal Cancer|June 17, 2022
Evaluation of UGT1A1 and CYP3A Genotyping and Single-Point Irinotecan and Metabolite Concentrations as Predictors of the Occurrence of Adverse Events in Cancer TreatmentJeziel Basso, Gilberto Schwartsmann, Mariana Rodrigues Ibaldi, et al.Journal of Gastrointestinal Cancer|June 2, 2022
Prognostic Factors in Resected Pancreatic Ductal Adenocarcinoma: Is Neutrophil-Lymphocyte Ratio a Useful Marker?Ignacio Merlo, Victoria Ardiles, Rodrigo Sanchez-Clariá, et al.Pageof 180